Payload Logo

10x Genomics: Q3 Earnings Snapshot

By AP News
Published

PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $93 million in its third quarter.

On a per-share basis, the Pleasanton, California-based company said it had a loss of 79 cents. Losses, adjusted for non-recurring costs, were 51 cents per share.

The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 45 cents per share.

The life science technology company posted revenue of $153.6 million in the period, which beat Street forecasts. Six analysts surveyed by Zacks expected $150.1 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TXG at https://www.zacks.com/ap/TXG

📬 Sign up for the Daily Brief

Our free, fast and fun briefing on the global economy, delivered every weekday morning.